Who Supplies Methotrexate? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Methotrexate exports, with 353+ registered manufacturers shipping to buyers across 148+ countries — yet a handful of companies dominate the shipments. CIPLA LIMITED holds the largest share at 35.1% (export value: $12.2M). Close behind, EUGIA PHARMA SPECIALITIES LIMITED (6.3%, $2.2M). INTAS PHARMACEUTICALS LIMITED (2.4%, $848.7K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Methotrexate? Top Manufacturers & Their Buyers
Flow of Methotrexate from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Methotrexate Supplier Network — Key Market Intelligence
The Methotrexate export market from India is led by CIPLA LIMITED, which alone commands a 35.1% share, shipping $12.2M worth of product across 217 shipments. The second-largest exporter, EUGIA PHARMA SPECIALITIES LIMITED, contributes $2.2M (6.3%) to the overall market. Combined, the top two suppliers alone account for 41.3% of all Methotrexate exports, indicating a relatively concentrated supply base.
Across all 353 tracked manufacturers, the total Methotrexate export value stands at $34.9M from 3.8K shipments. The market average shipment value is $9.2K. The single largest buyer relationship in terms of trade value is ALLOGA UK LTD, receiving $9.0M worth of product.
The combined buyer network spans 15 named purchasing companies, including ALLOGA UK LTD, PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR, GABAME S A DE C V, TO SAUDI AWAL BANK, ARROW PHARMACEUTICALS PTY LTD and 10 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1CIPLA LIMITED
CIPLA LIMITED is the first-largest Methotrexate exporter from India, with a market share of 35.1% and a total export value of $12.2M across 217 shipments. Their average shipment value of $56.4K is above the market average of $9.2K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. ALLOGA UK LTD is the dominant customer, accounting for 73.8% of this supplier's tracked business. Top customers include:
• ALLOGA UK LTD — $9.0M across 160 shipments (73.8% of this supplier's total exports)
• PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR — $1.1M across 20 shipments (9.4% of this supplier's total exports)
• GABAME S A DE C V — $873.4K across 15 shipments (7.1% of this supplier's total exports)
• TO SAUDI AWAL BANK — $599.3K across 11 shipments (4.9% of this supplier's total exports)
• ARROW PHARMACEUTICALS PTY LTD — $586.8K across 10 shipments (4.8% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $56.4K is 515% above the market average of $9.2K, consistent with large-order contracts or value-added formulations.
2EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Methotrexate exporter from India, with a market share of 6.3% and a total export value of $2.2M across 58 shipments. Their average shipment value of $37.7K is above the market average of $9.2K, suggesting premium or bulk contract pricing.
EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROBINDO PHARMA USA INC — $778.5K across 21 shipments (35.6% of this supplier's total exports)
• AUROBINDO PHARMA USA INC — $666.8K across 18 shipments (30.5% of this supplier's total exports)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $299.8K across 8 shipments (13.7% of this supplier's total exports)
• AUROBINDO PHARMA USA INC — $236.3K across 6 shipments (10.8% of this supplier's total exports)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $207.9K across 6 shipments (9.5% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $37.7K is 311% above the market average of $9.2K, consistent with large-order contracts or value-added formulations.
3INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the third-largest Methotrexate exporter from India, with a market share of 2.4% and a total export value of $848.7K across 109 shipments. Their average shipment value of $7.8K is below the market average of $9.2K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ACCORD FARMA S.A. DE — $372.9K across 48 shipments (43.9% of this supplier's total exports)
• XXCORXXHEAXXHCAXX IN — $140.7K across 18 shipments (16.6% of this supplier's total exports)
• ACCORD FARMA S.A. DE — $114.5K across 15 shipments (13.5% of this supplier's total exports)
• ACCORD HEALTHCARE INC — $113.3K across 15 shipments (13.4% of this supplier's total exports)
• ACCORD FARMA S.A. DE — $107.2K across 14 shipments (12.6% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (109 shipments) at a per-shipment value of $7.8K, indicating a broad distribution network with many smaller, regular orders.
4ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the fourth-largest Methotrexate exporter from India, with a market share of 2.2% and a total export value of $768.5K across 19 shipments. Their average shipment value of $40.4K is above the market average of $9.2K, suggesting premium or bulk contract pricing.
ZYDUS LIFESCIENCES LIMITED serves 1 named buyer in our database. XXDUSXXHARXXCEUXXCALXXUSAXXNC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• XXDUSXXHARXXCEUXXCALXXUSAXXNC — $768.5K across 19 shipments (100.0% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $40.4K is 341% above the market average of $9.2K, consistent with large-order contracts or value-added formulations.
5ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the fifth-largest Methotrexate exporter from India, with a market share of 2.1% and a total export value of $737.9K across 12 shipments. Their average shipment value of $61.5K is above the market average of $9.2K, suggesting premium or bulk contract pricing.
ALEMBIC PHARMACEUTICALS LIMITED serves 1 named buyer in our database. J. KNIPPER & COMPANY is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• J. KNIPPER & COMPANY — $737.9K across 12 shipments (100.0% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED's per-shipment value of $61.5K is 570% above the market average of $9.2K, consistent with large-order contracts or value-added formulations.
6NAPROD LIFE SCIENCES PRIVATE LIMITED
NAPROD LIFE SCIENCES PRIVATE LIMITED is the fifth-largest Methotrexate exporter from India, with a market share of 1.4% and a total export value of $474.9K across 45 shipments. Their average shipment value of $10.6K is above the market average of $9.2K, suggesting premium or bulk contract pricing.
NAPROD LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• PINYO PHARMACY LTD., PART — $214.7K across 20 shipments (45.2% of this supplier's total exports)
• PINYO PHARMACY LTD., PART — $90.3K across 9 shipments (19.0% of this supplier's total exports)
• PINYO PHARMACY LIMIT — $73.0K across 7 shipments (15.4% of this supplier's total exports)
• PINYO PHARMACY LIMIT — $51.9K across 5 shipments (10.9% of this supplier's total exports)
• MINISTERIO DE SALUD — $44.9K across 4 shipments (9.5% of this supplier's total exports)
Key Insight: NAPROD LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $10.6K is 15% above the market average of $9.2K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Methotrexate Flows
Once Methotrexate leaves the manufacturing plants of companies like CIPLA LIMITED and EUGIA PHARMA SPECIALITIES LIMITED, it travels to 5 destination markets with a combined import value of $34.9M. United Kingdom absorbs the largest share at 29.6% ($10.3M), followed by United States (16.3%) and Mexico (8.4%).
In United Kingdom — the top destination — named importers include ALLOGA UK LTD, MORNINGSIDE PHARMACEUTICAL LTD. In United States, key buyers are AUROBINDO PHARMA USA., INC,, AUROLOGISTICS LLC, (AUROBINDO PHARM, XXDUSXXHARXXCEUXXCALXXUSAXXNC.
This geographic spread reflects Methotrexate's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Methotrexate Go? Top Importing Countries & Their Buyers
Trade flow of Methotrexate exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United Kingdom
United Kingdom ranks as the first-largest destination for Methotrexate imports from India, with a total trade value of $10.3M across 68 shipments — representing a 29.6% share of all Methotrexate exports. The average shipment value of $151.9K is above the global average of $9.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Methotrexate importers in United Kingdom: ALLOGA UK LTD is the largest buyer, accounting for 88.0% ($9.1M) of this market's total imports.
• ALLOGA UK LTD — $9.1M (88.0% of United Kingdom's total)
• MORNINGSIDE PHARMACEUTICAL LTD — $455.4K (4.4% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $151.9K (1556% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Methotrexate imports from India.
2United States
United States ranks as the second-largest destination for Methotrexate imports from India, with a total trade value of $5.7M across 62 shipments — representing a 16.3% share of all Methotrexate exports. The average shipment value of $91.8K is above the global average of $9.2K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.
Named Methotrexate importers in United States: AUROBINDO PHARMA USA., INC, is the largest buyer, accounting for 16.1% ($919.5K) of this market's total imports.
• AUROBINDO PHARMA USA., INC, — $919.5K (16.1% of United States's total)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $799.8K (14.0% of United States's total)
• XXDUSXXHARXXCEUXXCALXXUSAXXNC — $768.5K (13.5% of United States's total)
Key Insight: United States's per-shipment average of $91.8K (901% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Methotrexate imports from India.
3Mexico
Mexico ranks as the third-largest destination for Methotrexate imports from India, with a total trade value of $2.9M across 12 shipments — representing a 8.4% share of all Methotrexate exports. The average shipment value of $243.6K is above the global average of $9.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Methotrexate importers in Mexico: GABAME S A DE C V is the largest buyer, accounting for 29.9% ($873.4K) of this market's total imports.
• GABAME S A DE C V — $873.4K (29.9% of Mexico's total)
• GABAME S A DE C V CALLE AV DE — $568.3K (19.4% of Mexico's total)
• GABAME S.A. DE C.V. — $421.3K (14.4% of Mexico's total)
Key Insight: Mexico's per-shipment average of $243.6K (2556% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mexico is a key market for Methotrexate imports from India.
4Saudi Arabia
Saudi Arabia ranks as the fourth-largest destination for Methotrexate imports from India, with a total trade value of $1.8M across 5 shipments — representing a 5.2% share of all Methotrexate exports. The average shipment value of $364.6K is above the global average of $9.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Methotrexate importers in Saudi Arabia: SUDAIR PHARMA COMPANY is the largest buyer, accounting for 33.6% ($613.4K) of this market's total imports.
• SUDAIR PHARMA COMPANY — $613.4K (33.6% of Saudi Arabia's total)
• TO SAUDI AWAL BANK — $599.3K (32.9% of Saudi Arabia's total)
Key Insight: Saudi Arabia's per-shipment average of $364.6K (3874% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Methotrexate imports from India.
5Turkey
Turkey ranks as the fifth-largest destination for Methotrexate imports from India, with a total trade value of $1.7M across 12 shipments — representing a 4.9% share of all Methotrexate exports. The average shipment value of $143.8K is above the global average of $9.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Methotrexate importers in Turkey: PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR is the largest buyer, accounting for 92.7% ($1.6M) of this market's total imports.
• PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR — $1.6M (92.7% of Turkey's total)
Key Insight: Turkey's per-shipment average of $143.8K (1468% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Turkey is a key market for Methotrexate imports from India.
People Also Ask — Methotrexate Supplier & Trade Network
Who are the top suppliers of Methotrexate from India?+
Which companies buy Methotrexate from Indian manufacturers?+
Where does Methotrexate exported from India go?+
What is the market share of the top Methotrexate supplier from India?+
What is the average shipment value for Methotrexate exports from India?+
Is Methotrexate manufactured in India and exported globally?+
Which country imports the most Methotrexate from India?+
Who are the buyers of Methotrexate in United States?+
How concentrated is the Methotrexate supplier market in India?+
How do I find verified buyers for Methotrexate in specific countries?+
Methotrexate Trade Network — Key Takeaways
- 1CIPLA LIMITED is India's dominant Methotrexate exporter with a 35.1% market share and $12.2M in total exports — making it the single most important sourcing entity in this market.
- 2The top 353 suppliers collectively account for 49.4% of all tracked Methotrexate exports, with a combined trade value of $34.9M.
- 3United Kingdom is the largest destination market, absorbing 29.6% of India's Methotrexate exports ($10.3M). United States (16.3%) and Mexico (8.4%) follow.
- 4With 3.8K total shipments averaging $9.2K each, the Methotrexate export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include ALLOGA UK LTD, PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR, AUROBINDO PHARMA USA INC, AUROBINDO PHARMA USA INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 148 countries
Network value: $34.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Methotrexate — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Methotrexate.
- 2.Flow Mapping: 353 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,806 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 148 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,806 Verified Shipments
353 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists